NEW YORK (GenomeWeb) – Pacific Biosciences said this week that it would continue to ramp up shipments of SMRT cells for its Sequel instrument, which it launched on a limited basis last year.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.
A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.
In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.
Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.
This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.
This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.
Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.
In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.